FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163568592> ?p ?o ?g. }

• W3163568592 abstract "Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally. Individuals should have their risk factors monitored and clinically managed to lower this risk, and many countries adopt similar prevention strategies targeting those at highest risk. One such high-risk group are those who have previously experienced a cardiovascular event, and consequently these patients are universally identified and targeted in risk management strategies. This thesis initially compared recommendations for the management of lipids in secondary prevention populations in a systematic review of national clinical guidelines. This found that statins were consistently recommended, but there were substantial differences in the use of lipid targets and the frequency of lipid monitoring after statin initiation, although annual lipid tests were the most frequently recommended. Aside from expert opinion, however, there was little robust evidence to support the recommendations for targets and monitoring frequency. Therefore, the frequency of lipid testing under the current guidelines is unlikely to be optimal for the management of many patients. Increased use of electronic health records could allow the development of algorithms to result in a personalised approach to lipid testing. Specifically, if most patients have lipid tests annually, the possibility that there are a group of patients that need less frequent monitoring can be assessed. The remainder of this thesis, therefore, aimed to explore this within a subgroup of the secondary prevention population, survivors of myocardial infarctions (MIs), within Greater Glasgow and Clyde (GGC), where current and previous guidelines recommend an annual lipid test. To achieve this, the cohort was first described to facilitate comparisons with external literature and to understand the ongoing real-life clinical management of these patients. Associations between adherence and the achievement of guideline-recommended lipid targets were then investigated with further hospitalisations for MIs and mortality. Finally, factors associated with non-adherence and non-target lipids were identified and used to predict patients’ subsequent adherence and cholesterol levels, i.e. those who could receive reduced lipid monitoring. Data was obtained from NHS GGC’s Safe Haven for 11,110 patients who experienced a non-fatal MI between 2009 and 2014, with follow up available until July 2017. Demographics were consistent with similar observational cohorts from other countries in the literature, including a greater proportion of males to females, an average age of 67 years, and approximately a fifth diagnosed with diabetes before their baseline MI. Estimated statin adherence, obtained through encashed prescribing records, found that two thirds achieved an average adherence during follow up ≥80% and 85% ≥50%. Three quarters of those with at least one lipid test achieved LDL ≤1.8mmol/l during follow up. Statin adherence did not fully account for LDL target achievement, but those with higher adherence were significantly more likely to achieve it.High adherence and lipid target attainment were common suggesting that there was a subset of patients for whom an annual lipid test could be considered unnecessary, as a further lipid test was unlikely to change any clinical decisions. Non-adherence and elevated lipids were separately significantly associated with increased mortality within this cohort ( 1.8mmol/l: 1.3 (1.2-1.4)), and with CVD mortality specifically ( 1.8mmol/l: 1.3 (1.1-1.5)). Therefore, careful and accurate identification of low risk patients is needed to avoid increased mortality.Latent class analysis, a type of mixture model for categorical variables, was implemented to explore clustering and patterns within the data associated with lipid target achievement and adherence, into latent classes. For LDL ≤1.8mmol/l, sensitivity of these classes was 83% and positive predictive value was 100%, meaning all those predicted to achieve the target did so. This positive predictive value was also observed when ≥50% adherence was considered, and sensitivity was 99%. The class share of those predicted to have ≥50% adherence was substantially larger, with 85% predicted to do so, compared to 42% for LDL ≤1.8mmol/l. Associations between predicted classes and mortality showed that those predicted to have ≥50% adherence experienced lower rates of mortality, than those predicted not to. This was not the case for the LDL ≤1.8mmol/l, although the predictions performed no worse than those observed. In conclusion, given lipid tests as part of an annual review can be expensive in terms of the time needed for repeat appointments and biochemistry, the purpose of these for secondary prevention CVD patients needs to be considered and clarified by guideline committees. Once a patient meets a lipid target and adherence continues to be high, clinical decisions are unlikely to change with further blood tests. The results in this thesis have shown that using previous adherence and lipid results, and demographic information, patients’ adherence can be accurately predicted and therefore could be used as a practical marker of lipid test’s necessity within a review. However, before the implementation of this approach should be considered, further validation of these results within other external observational cohorts is required, and a non-inferiority randomised controlled trial should also be implemented." @default.
• W3163568592 created "2021-05-24" @default.
• W3163568592 creator A5045840472 @default.
• W3163568592 date "2021-01-01" @default.
• W3163568592 modified "2023-09-24" @default.
• W3163568592 title "A precision medicine approach to lipid monitoring in the secondary prevention of cardiovascular disease" @default.
• W3163568592 cites W1504518491 @default.
• W3163568592 cites W1559795939 @default.
• W3163568592 cites W1580788756 @default.
• W3163568592 cites W1585594192 @default.
• W3163568592 cites W1730972729 @default.
• W3163568592 cites W1964862986 @default.
• W3163568592 cites W1968893448 @default.
• W3163568592 cites W1977247044 @default.
• W3163568592 cites W1983951055 @default.
• W3163568592 cites W1987734023 @default.
• W3163568592 cites W1989985225 @default.
• W3163568592 cites W1992295255 @default.
• W3163568592 cites W199262836 @default.
• W3163568592 cites W1993816606 @default.
• W3163568592 cites W2015410646 @default.
• W3163568592 cites W2019071303 @default.
• W3163568592 cites W2032130021 @default.
• W3163568592 cites W2040462758 @default.
• W3163568592 cites W2048760408 @default.
• W3163568592 cites W2048919469 @default.
• W3163568592 cites W2053154970 @default.
• W3163568592 cites W2054931962 @default.
• W3163568592 cites W2055838663 @default.
• W3163568592 cites W2057907723 @default.
• W3163568592 cites W2058622522 @default.
• W3163568592 cites W2058769762 @default.
• W3163568592 cites W2060615057 @default.
• W3163568592 cites W2061736358 @default.
• W3163568592 cites W2067694868 @default.
• W3163568592 cites W2073486233 @default.
• W3163568592 cites W2079972091 @default.
• W3163568592 cites W2081913577 @default.
• W3163568592 cites W2082965216 @default.
• W3163568592 cites W2090728047 @default.
• W3163568592 cites W2098704212 @default.
• W3163568592 cites W2101621119 @default.
• W3163568592 cites W2103018859 @default.
• W3163568592 cites W2109003937 @default.
• W3163568592 cites W2109129984 @default.
• W3163568592 cites W2110052313 @default.
• W3163568592 cites W2111099202 @default.
• W3163568592 cites W2113320440 @default.
• W3163568592 cites W2115169717 @default.
• W3163568592 cites W2118079952 @default.
• W3163568592 cites W2118184073 @default.
• W3163568592 cites W2118825330 @default.
• W3163568592 cites W2119852447 @default.
• W3163568592 cites W2121408450 @default.
• W3163568592 cites W2121568629 @default.
• W3163568592 cites W2126874967 @default.
• W3163568592 cites W2127670404 @default.
• W3163568592 cites W2129688566 @default.
• W3163568592 cites W2143450493 @default.
• W3163568592 cites W2149030597 @default.
• W3163568592 cites W2151247869 @default.
• W3163568592 cites W2155121555 @default.
• W3163568592 cites W2155311570 @default.
• W3163568592 cites W2155598961 @default.
• W3163568592 cites W2156992711 @default.
• W3163568592 cites W2160180868 @default.
• W3163568592 cites W2164089346 @default.
• W3163568592 cites W2164777277 @default.
• W3163568592 cites W2165624352 @default.
• W3163568592 cites W2166000498 @default.
• W3163568592 cites W2167939282 @default.
• W3163568592 cites W2170652936 @default.
• W3163568592 cites W2171814052 @default.
• W3163568592 cites W2177167156 @default.
• W3163568592 cites W2181092548 @default.
• W3163568592 cites W2261871796 @default.
• W3163568592 cites W2264654258 @default.
• W3163568592 cites W2264767503 @default.
• W3163568592 cites W2281579750 @default.
• W3163568592 cites W2294500753 @default.
• W3163568592 cites W2300129093 @default.
• W3163568592 cites W2312931650 @default.
• W3163568592 cites W2326757113 @default.
• W3163568592 cites W2331820709 @default.
• W3163568592 cites W2333650076 @default.
• W3163568592 cites W2339800103 @default.
• W3163568592 cites W2402599050 @default.
• W3163568592 cites W2412716424 @default.
• W3163568592 cites W2416897121 @default.
• W3163568592 cites W2418398890 @default.
• W3163568592 cites W2460492626 @default.
• W3163568592 cites W2466908408 @default.
• W3163568592 cites W2473256880 @default.
• W3163568592 cites W2485118186 @default.
• W3163568592 cites W2491519456 @default.
• W3163568592 cites W2519634482 @default.
• W3163568592 cites W2528966414 @default.
• W3163568592 cites W2531198978 @default.
• W3163568592 cites W2551364930 @default.
• W3163568592 cites W2556846762 @default.

• next